RIGL 8-K 2026-01-12

RIGEL PHARMACEUTICALS INC (RIGL) 8-K dated 2026-01-12 — accession 0001034842-26-000005. This URL is the filing, not the RIGL hub.

RIGEL PHARMACEUTICALS INC (RIGL) is a biotechnology company listed on US.

RIGEL PHARMACEUTICALS INC filed a 8-K on 2026-01-12. Accession 0001034842-26-000005.

Cached items: 2.02, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RIGL revenue for 2025-12-31 was $294.3M. Net income was $367.0M. Revenue was up 64.1% from 2024-12-31 to 2025-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 2.9.

Not investment advice. The RIGL SEC hub lists recent forms. The stock page is the research view.